India, Feb. 1 -- Chime Biologics has a vision to make biologics more accessible and affordable. How does this vision drive your day-to-day operations and long-term strategies?

We are committed to being a global CDMO with industry-leading capabilities and efficiency, focusing on operational excellence and cost reduction. This vision drives our one-centre strategy, which centralises all operations at our single operational centre unlike multiple facilities favoured by some competitors. With this strategy, we ensure streamlined processes and minimal duplication, significantly reducing the costs of manufacturing while maintaining high quality. For example, as we expand our manufacturing capacity from 10,000L to 30,000L by 2025-a threefold in...